2006CCO復(fù)發(fā)性小細(xì)胞肺癌的化療治療
《2006CCO復(fù)發(fā)性小細(xì)胞肺癌的化療治療》內(nèi)容簡介：
What are the front-line chemotherapeutic options for women with recurrent, metastatic, orpersistent cervical cancer? Outcomes of interest include response rate, survival, toxicity, andquality of life （QOL）。
《2006CCO復(fù)發(fā)性小細(xì)胞肺癌的化療治療》內(nèi)容預(yù)覽：
Carcinoma of the cervix is the third most common female genital tract malignancy in Canada,accounting for an estimated 1350 new cases and 400 deaths in 2005 （1）。 Although the rate ofincidence has declined dramatically over the past decades, cervical cancer contributes to 510new cases and 160 deaths each year in Ontario alone （1）。 The prognosis for early-stagecervical cancer is good due to effective screening practices and early treatments involvingsurgery and radiotherapy （2）。 In patients with high-risk local disease or advanced disease, theuse of radiosensitizing chemotherapy, typically cisplatin, improves survival outcomes overradiotherapy alone and has become a standard of care （3）； however, five-year survival forpatients with recurrent or persistent cervical cancer is less than 5% （4）。 Due to the increasinguse of cisplatin as a radiosensitizer in primary therapy, the effectiveness of cisplatin alone or incombination for first-line treatment is not well defined for this patient population.
點擊下載***：《2006CCO復(fù)發(fā)性小細(xì)胞肺癌的化療治療》
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個人可與我們
聯(lián)系zlzs@120.net，我們將立即進行刪除處理
熱點圖文
-
2013我國胰腺囊性腫瘤共識意見草案
本共識意見（草案）依據(jù)我國胰腺囊性腫瘤的最近研究，并參考國際相關(guān)指南和研究...[詳細(xì)]
-
2013NCCN結(jié)直腸癌指南
在美國，結(jié)直腸癌發(fā)病率占所有癌癥的第四位，而死亡率為第二位。2012年估計...[詳細(xì)]
